Global healthscience consultancy Oxford PharmaGenesis has received menopause-friendly employer accreditation as part of its commitment to support its employees as their lives evolve.
Established by Henpicked: Menopause in the Workplace, the accreditation recognises high standards and proven practices that embrace menopause in the workplace. To achieve it, employers are assessed by an independent panel and demonstrate their effectiveness in culture, policies and practices, training, engagement, facilities and evaluation.
The consultancy received accreditation due to the success of its menopause advocates in representing different perspectives and developing its offering, acting on an in-depth review of its facilities and support to make life easier for employees, and creating an environment through education and training processes where menopause is commonly and openly discussed, and is natural topic of conversation and area of support.
Oxford PharmaGenesis explained that the accreditation will help it to attract senior women in an inclusive manner, and achieve an open communication that supports breaking biases to help staff discuss their personal circumstances for a more tailored approach.
Sharon Frost, global HR director at Oxford PharmaGenesis, said: “As a majority-female populated organisation, it is an honour to have been accredited as a menopause-friendly employer in recognition of the collective work that has taken place at Oxford PharmaGenesis to break down bias in the workplace on a topic affecting many of our current and future colleagues. I would like to thank our advocates for their hard work and our colleagues who shared their lived experiences to help us create a workplace that now better serves them.”
Deborah Garlick, chief executive officer of Henpicked: Menopause in the Workplace, added: “Oxford PharmaGenesis valued most highly the structure that the accreditation process provides to help it deliver an ongoing programme that has rigour and is truly meaningful. It’s wonderful to hear it is now thinking more broadly and see being menopause-friendly as an ongoing process that will evolve and improve its support of colleagues in this area.”
